arrow
M

Melinda G. Hollingshead

Frederick National Laboratory for Cancer Research
H指数:53
被引数:9,561

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types

RAS通路抑制剂与靶向药物联用对携带致癌性KRAS变异的多种癌症来源的类器官球体有效

2025-10-010
OAAI
Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas

I期研究评估吲哚异喹啉类化合物LMP776和LMP744在实体瘤和淋巴瘤患者中的应用

2025-05-290
OAAI
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis
2024-07-021
OAAI
Cholangiocarcinoma patient-derived models in the NCI Patient-Derived Models Repository
2024-03-220
PRE
Genomic landscape and stability of preclinical models in NCI's patient-derived models repository
2024-03-220
PRE
Biochemical inhibition profiles of 370 wild type human kinases provide a basis for selecting alternative combinations of EGFR and VEGFR inhibitors
2023-04-040
PRE
Combination therapies in matched 3D in vitro and in vivo preclinical models of rare and recalcitrant cancers from the National Cancer Institute's Patient-Derived Models Repository
2023-04-040
PRE
Molecular subclassification of NCI PDMR breast cancer models using PAM50 gene expression signature
2023-04-040
PRE
A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis
2023-04-040
PRE
NCI patient derived models repository: PDX, organoid and cell lines from the same patient - bridging the translational pipeline
2023-04-040
PRE
Chromosomal aneuploidy, whole-genome doubling and mutational signatures in NCI PDMR models
2023-04-040
PRE
Comparing twenty-two matched patient-derived cell lines developed from either patient, PDX, or organoid tumor cell material
2023-04-040
PRE